The objective of this study was to validate and update the Amsterdam prediction model including tumor grade, lymph node ratio, margin status and adjuvant therapy, for prediction of overall survival (OS) after pancreatoduodenectomy for pancreatic cancer.
Product ID:
114121
Handle IRIS:
11562/1016749
Last Modified:
November 15, 2022
Bibliographic citation:
van Roessel, Stijn; Strijker, Marin; Steyerberg, Ewout W; Groen, Jesse V; Mieog, J Sven; Groot, Vincent P; He, Jin; De Pastena, Matteo; Marchegiani, Giovanni; Bassi, Claudio; Suhool, Amal; Jang, Jin-Young; Busch, Olivier R; Halimi, Asif; Zarantonello, Laura; Groot Koerkamp, Bas; Samra, Jaswinder S; Mittal, Anubhav; Gill, Anthony J; Bolm, Louisa; van Eijck, Casper H; Abu Hilal, Mohammed; Del Chiaro, Marco; Keck, Tobias; Alseidi, Adnan; Wolfgang, Christopher L; Malleo, Giuseppe; Besselink, Marc G,
International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer«European Journal of Surgical Oncology»
, vol. 46
, n. 5
, 2020
, pp. 796-803